Literature DB >> 29770434

Tumour YAP1 and PTEN expression correlates with tumour-associated myeloid suppressor cell expansion and reduced survival in colorectal cancer.

Rong Yang1, Ting-Ting Cai1, Xiao-Jun Wu1,2, Yi-Na Liu1, Jia He3, Xiao-Shi Zhang1,3, Gang Ma4, Jiang Li1,3.   

Abstract

The expansion of myeloid-derived suppressor cells (MDSCs) correlates with tumorigenesis in colorectal cancer (CRC). Here, we found a significant association between CD33+ MDSC number and Yes-associated protein 1 (YAP1) and phosphatase and tensin homologue (PTEN) levels in CRC patients (P < 0·05). Moreover, the CD33+ MDSCs, YAP1 and PTEN were identified as predictors for the prognosis of CRC patients (P < 0·05). Notably, CD33+ MDSCs were an independent survival predictor for CRC patients through a Cox model analysis. In vitro data determined that the expression levels of YAP1 and PTEN in CRC-derived cell lines were associated with CRC-derived MDSC induction, and the blockade of YAP1 and PTEN decreased CRC-derived MDSC induction. A mechanistic analysis revealed that YAP1 promoted CRC-derived MDSC induction by suppressing PTEN expression to up-regulate COX-2, P-AKT and P-p65 in CRC-derived cells, leading to secretion of the cytokine granulocyte-macrophage colony-stimulating factor. Our findings establish a novel mechanism of pro-tumorigenic MDSC induction mediated by ectopic YAP1 and PTEN expression in CRC.
© 2018 John Wiley & Sons Ltd.

Entities:  

Keywords:  colorectal cancer; myeloid-derived suppressor cell; phosphatase and tensin homologue; prognosis; yes-associated protein 1

Mesh:

Substances:

Year:  2018        PMID: 29770434      PMCID: PMC6142285          DOI: 10.1111/imm.12949

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  26 in total

1.  YAP mediates crosstalk between the Hippo and PI(3)K–TOR pathways by suppressing PTEN via miR-29.

Authors:  Karen Tumaneng; Karin Schlegelmilch; Ryan C Russell; Dean Yimlamai; Harihar Basnet; Navin Mahadevan; Julien Fitamant; Nabeel Bardeesy; Fernando D Camargo; Kun-Liang Guan
Journal:  Nat Cell Biol       Date:  2012-12       Impact factor: 28.824

2.  Wnt/β-catenin signaling regulates Yes-associated protein (YAP) gene expression in colorectal carcinoma cells.

Authors:  Wesley M Konsavage; Sydney L Kyler; Sherri A Rennoll; Ge Jin; Gregory S Yochum
Journal:  J Biol Chem       Date:  2012-02-15       Impact factor: 5.157

Review 3.  Myeloid-derived suppressor cells in the tumor microenvironment: expect the unexpected.

Authors:  Douglas Marvel; Dmitry I Gabrilovich
Journal:  J Clin Invest       Date:  2015-07-13       Impact factor: 14.808

4.  Effects of MAPK and PI3K pathways on PD-L1 expression in melanoma.

Authors:  Mohammad Atefi; Earl Avramis; Amanda Lassen; Deborah J L Wong; Lidia Robert; David Foulad; Michael Cerniglia; Bjoern Titz; Thinle Chodon; Thomas G Graeber; Begonya Comin-Anduix; Antoni Ribas
Journal:  Clin Cancer Res       Date:  2014-05-08       Impact factor: 12.531

5.  Interferon regulatory factor 8 functions as a tumor suppressor in renal cell carcinoma and its promoter methylation is associated with patient poor prognosis.

Authors:  Qian Zhang; Lian Zhang; LiLi Li; Zhaohui Wang; Jianming Ying; Yu Fan; Ben Xu; Lu Wang; Qianling Liu; Guangfu Chen; Qian Tao; Jie Jin
Journal:  Cancer Lett       Date:  2014-08-07       Impact factor: 8.679

6.  Loss of PTEN Promotes Resistance to T Cell-Mediated Immunotherapy.

Authors:  Weiyi Peng; Jie Qing Chen; Chengwen Liu; Shruti Malu; Caitlin Creasy; Michael T Tetzlaff; Chunyu Xu; Jodi A McKenzie; Chunlei Zhang; Xiaoxuan Liang; Leila J Williams; Wanleng Deng; Guo Chen; Rina Mbofung; Alexander J Lazar; Carlos A Torres-Cabala; Zachary A Cooper; Pei-Ling Chen; Trang N Tieu; Stefani Spranger; Xiaoxing Yu; Chantale Bernatchez; Marie-Andree Forget; Cara Haymaker; Rodabe Amaria; Jennifer L McQuade; Isabella C Glitza; Tina Cascone; Haiyan S Li; Lawrence N Kwong; Timothy P Heffernan; Jianhua Hu; Roland L Bassett; Marcus W Bosenberg; Scott E Woodman; Willem W Overwijk; Gregory Lizée; Jason Roszik; Thomas F Gajewski; Jennifer A Wargo; Jeffrey E Gershenwald; Laszlo Radvanyi; Michael A Davies; Patrick Hwu
Journal:  Cancer Discov       Date:  2015-12-08       Impact factor: 39.397

7.  Targeting YAP-Dependent MDSC Infiltration Impairs Tumor Progression.

Authors:  Guocan Wang; Xin Lu; Prasenjit Dey; Pingna Deng; Chia Chin Wu; Shan Jiang; Zhuangna Fang; Kun Zhao; Ramakrishna Konaparthi; Sujun Hua; Jianhua Zhang; Elsa M Li-Ning-Tapia; Avnish Kapoor; Chang-Jiun Wu; Neelay Bhaskar Patel; Zhenglin Guo; Vandhana Ramamoorthy; Trang N Tieu; Tim Heffernan; Di Zhao; Xiaoying Shang; Sunada Khadka; Pingping Hou; Baoli Hu; Eun-Jung Jin; Wantong Yao; Xiaolu Pan; Zhihu Ding; Yanxia Shi; Liren Li; Qing Chang; Patricia Troncoso; Christopher J Logothetis; Mark J McArthur; Lynda Chin; Y Alan Wang; Ronald A DePinho
Journal:  Cancer Discov       Date:  2015-12-23       Impact factor: 39.397

8.  Tumor-selective proteotoxicity of verteporfin inhibits colon cancer progression independently of YAP1.

Authors:  Huabing Zhang; Sadeesh K Ramakrishnan; Daniel Triner; Brook Centofanti; Dhiman Maitra; Balázs Győrffy; Judith S Sebolt-Leopold; Michael K Dame; James Varani; Dean E Brenner; Eric R Fearon; M Bishr Omary; Yatrik M Shah
Journal:  Sci Signal       Date:  2015-10-06       Impact factor: 8.192

9.  The incidence and mortality of major cancers in China, 2012.

Authors:  Wanqing Chen; Rongshou Zheng; Hongmei Zeng; Siwei Zhang
Journal:  Chin J Cancer       Date:  2016-08-02

10.  Expression of hippo pathway in colorectal cancer.

Authors:  Kun Liang; Guangxi Zhou; Qi Zhang; Jing Li; Cuiping Zhang
Journal:  Saudi J Gastroenterol       Date:  2014 May-Jun       Impact factor: 2.485

View more
  13 in total

Review 1.  Drug Resistance in Colorectal Cancer: From Mechanism to Clinic.

Authors:  Qianyu Wang; Xiaofei Shen; Gang Chen; Junfeng Du
Journal:  Cancers (Basel)       Date:  2022-06-14       Impact factor: 6.575

2.  High cytoplasmic YAP1 expression predicts a poor prognosis in patients with colorectal cancer.

Authors:  Tianqi Dong; Yuncang Yuan; Xudong Xiang; Shuping Sang; Hao Shen; Lei Wang; Chunyan Yang; Fangfang Li; Hongliang Li; Shangyong Zheng
Journal:  PeerJ       Date:  2020-11-19       Impact factor: 2.984

Review 3.  Emerging role of PTEN loss in evasion of the immune response to tumours.

Authors:  Thiago Vidotto; Camila Morais Melo; Erick Castelli; Madhuri Koti; Rodolfo Borges Dos Reis; Jeremy A Squire
Journal:  Br J Cancer       Date:  2020-04-24       Impact factor: 7.640

4.  Yes-Associated Protein 1 as a Novel Prognostic Biomarker for Gastrointestinal Cancer: A Meta-Analysis.

Authors:  Luo Zhang; Xing Song; Xiaodong Li; Changping Wu; Jingting Jiang
Journal:  Biomed Res Int       Date:  2018-11-14       Impact factor: 3.411

Review 5.  Myeloid-Derived Suppressor Cells: A New and Pivotal Player in Colorectal Cancer Progression.

Authors:  Kai Yin; Xueli Xia; Ke Rui; Tingting Wang; Shengjun Wang
Journal:  Front Oncol       Date:  2020-12-15       Impact factor: 6.244

6.  A core of differentially methylated CpG loci in gMDSCs isolated from neonatal and adult sources.

Authors:  Isabella Berglund-Brown; Emily Nissen; Devin C Koestler; Rondi A Butler; Melissa N Eliot; James F Padbury; Lucas A Salas; Annette M Molinaro; Brock C Christensen; John K Wiencke; Karl T Kelsey
Journal:  Clin Epigenetics       Date:  2022-02-21       Impact factor: 7.259

7.  Reactivation of the tumor suppressor PTEN by mRNA nanoparticles enhances antitumor immunity in preclinical models.

Authors:  Yao-Xin Lin; Yi Wang; Jianxun Ding; Aiping Jiang; Jie Wang; Mian Yu; Sara Blake; Shuaishuai Liu; Charles J Bieberich; Omid C Farokhzad; Lin Mei; Hao Wang; Jinjun Shi
Journal:  Sci Transl Med       Date:  2021-06-23       Impact factor: 17.956

8.  Gastric Cancer Cell-Derived Exosomal microRNA-23a Promotes Angiogenesis by Targeting PTEN.

Authors:  Jiang Du; Yuan Liang; Ji Li; Jin-Ming Zhao; Xu-Yong Lin
Journal:  Front Oncol       Date:  2020-03-13       Impact factor: 6.244

Review 9.  The New Era of Cancer Immunotherapy: Targeting Myeloid-Derived Suppressor Cells to Overcome Immune Evasion.

Authors:  Paola De Cicco; Giuseppe Ercolano; Angela Ianaro
Journal:  Front Immunol       Date:  2020-07-30       Impact factor: 7.561

Review 10.  YAP/Hippo Pathway and Cancer Immunity: It Takes Two to Tango.

Authors:  Dimitrios Matthaios; Maria Tolia; Davide Mauri; Konstantinos Kamposioras; Michalis Karamouzis
Journal:  Biomedicines       Date:  2021-12-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.